OXFORD FINANCIAL GROUP LTD – Lineage Cell Therapeutics, Inc. Transaction History
OXFORD FINANCIAL GROUP LTD portfolio value:
$14,000
portfolio value
OXFORD FINANCIAL GROUP LTD quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -6K | $1.13 | 12.63K | |
| Q2 2022 | share | 0.00% | 0 shares | 1K | $1.58 | 12.63K | |
| Q1 2022 | share | 0.00% | 0 shares | -12K | $1.54 | 12.63K | |
| Q4 2021 | share | 0.00% | 0 shares | -1K | $2.5 | 12.63K | |
| Q3 2021 | share | 0.00% | 0 shares | -4K | $2.52 | 12.63K | |
| Q2 2021 | share | 0.00% | 0 shares | 6K | $2.85 | 12.63K | |
| Q1 2021 | share | 0.00% | 0 shares | 8K | $2.35 | 12.63K | |
| Q4 2020 | share | Increase | 0.00% | 12.63K shares | 22K | $1.76 | 12.63K |